Abstract:BACKGROUND:An individual's rate of aging directly influences his/her susceptibility to morbidity and mortality. Thus, quantifying aging and disentangling how various factors coalesce to produce between-person differences in the rate of aging, have important implications for potential interventions. We recently developed and validated a novel multi-system-based aging measure, Phenotypic Age (PhenoAge), which has been shown to capture mortality and morbidity risk in the full US population and diverse subpopulations. The aim of this study was to evaluate associations between PhenoAge and a comprehensive set of factors, including genetic scores, childhood and adulthood circumstances, and health behaviors, to determine the relative contributions of these factors to variance in this aging measure.METHODS AND FINDINGS:Based on data from 2,339 adults (aged 51+ years, mean age 69.4 years, 56% female, and 93.9% non-Hispanic white) from the US Health and Retirement Study, we calculated PhenoAge and evaluated the multivariable associations for a comprehensive set of factors using 2 innovative approaches-Shapley value decomposition (the Shapley approach hereafter) and hierarchical clustering. The Shapley approach revealed that together all 11 study domains (4 childhood and adulthood circumstances domains, 5 polygenic score [PGS] domains, and 1 behavior domain, and 1 demographic domain) accounted for 29.2% (bootstrap standard error = 0.003) of variance in PhenoAge after adjustment for chronological age. Behaviors exhibited the greatest contribution to PhenoAge (9.2%), closely followed by adulthood adversity, which was suggested to contribute 9.0% of the variance in PhenoAge. Collectively, the PGSs contributed 3.8% of the variance in PhenoAge (after accounting for chronological age). Next, using hierarchical clustering, we identified 6 distinct subpopulations based on the 4 childhood and adulthood circumstances domains. Two of these subpopulations stood out as disadvantaged, exhibiting significantly higher PhenoAges on average. Finally, we observed a significant gene-by-environment interaction between a previously validated PGS for coronary artery disease and the seemingly most disadvantaged subpopulation, suggesting a multiplicative effect of adverse life course circumstances coupled with genetic risk on phenotypic aging. The main limitations of this study were the retrospective nature of self-reported circumstances, leading to possible recall biases, and the unrepresentative racial/ethnic makeup of the population.CONCLUSIONS:In a sample of US older adults, genetic, behavioral, and socioenvironmental circumstances during childhood and adulthood account for about 30% of differences in phenotypic aging. Our results also suggest that the detrimental effects of disadvantaged life course circumstances for health and aging may be further exacerbated among persons with genetic predisposition to coronary artery disease. Finally, our finding that behaviors had the largest contribution to PhenoAge highlights a potential policy target. Nevertheless, further validation of these findings and identification of causal links are greatly needed.

Differential white blood cell count and epigenetic clocks: a bidirectional Mendelian randomization study

Comparative analysis of epigenetic aging clocks from CpG characteristics to functional associations

Mendelian randomization analysis reveals the combined effects of epigenetics and telomere biology in hematologic cancers

Effects of iron homeostasis on epigenetic age acceleration: a two-sample Mendelian randomization study

Analyzing the causal role of blood cells in aging: a Mendelian randomization study

Genetic relationship between ageing and coronary heart disease: a Mendelian randomization study

Exploring the causal association between epigenetic clocks and menopause age: insights from a bidirectional Mendelian randomization study

Refining epigenetic prediction of chronological and biological age

Genetic association of the gut microbiota with epigenetic clocks mediated by inflammatory cytokines: a Mendelian randomization analysis

Trends of genetic contributions on epigenetic clocks and related methylation sites with aging: A population‐based adult twin study

Epigenetic drift underlies epigenetic clock signals, but displays distinct responses to lifespan interventions, development, and cellular dedifferentiation

Causal association of obesity with epigenetic aging and telomere length: a bidirectional mendelian randomization study

The Significant Associations between Epigenetic Clocks and Bladder Cancer Risks

New insights from bidirectional Mendelian randomization: causal relationships between telomere length and mitochondrial DNA copy number in aging biomarkers

Associations of Genetics, Behaviors, and Life Course Circumstances with a Novel Aging and Healthspan Measure: Evidence from the Health and Retirement Study.

An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease

Underlying features of epigenetic aging clocks in vivo and in vitro

Dissecting the impact of differentiation stage, replicative history, and cell type composition on epigenetic clocks

Cell-type specific epigenetic clocks to quantify biological age at cell-type resolution

Causal inference for epigenetic ageing

When to Trust Epigenetic Clocks: Avoiding False Positives in Aging Interventions.